Ann: Proteomics raises $8m in highly successful Placement, page-13

Lost Dollar you are right on the money when you say, PIQ just need to concentrate on the commercialization of these test. No amount of positive lab results or peer reviewed studdies means diddly squat if the management has no commercial acumen. Its "nice" hearing Richard say exciting new announcements regarding Endonetriosis and Oesophagal cancer but lets just concentrate on making Promarker D a commercial success first. Afterall, if they cant sell a revolutionary test right into the heart of world Diabetes pandemic globally, then frankly no end of fluffy announcements like these are going to matter one iota. This is a publically funded company and shareholders expect a timely return on investment for risk endured. That return on investment takes bipartisan form. A constant but sustained increase in share price as well as a dividend returned to stake holders. We are not here to pander to Richards academic ego, we want results delivered in a timely manner and that time is now. Get cash flow positive soon or sell out to any number of players who can bring this to market globally, ones who have the experience, contacts and track record of delivering new biochemical assays. l give PIQ another 6 months to demonstrate a clear path forward and surpass earlier SP highs or l liquidate my 180,000 shares.